Ascentage Pharma Group International (AAPG) Finished Goods (2023 - 2025)
Ascentage Pharma Group International (AAPG) has disclosed Finished Goods for 3 consecutive years, with $1.0 million as the latest value for Q4 2025.
- For Q4 2025, Finished Goods rose 94.81% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, up 94.81%, while the annual FY2025 figure was $1.1 million, 100.38% up from the prior year.
- Finished Goods hit $1.0 million in Q4 2025 for Ascentage Pharma Group International, up from $537511.9 in the prior quarter.
- Across five years, Finished Goods topped out at $1.5 million in Q4 2023 and bottomed at $537511.9 in Q4 2024.
- Average Finished Goods over 3 years is $1.0 million, with a median of $1.0 million recorded in 2025.
- Year-over-year, Finished Goods tumbled 65.06% in 2024 and then soared 94.81% in 2025.
- Ascentage Pharma Group International's Finished Goods stood at $1.5 million in 2023, then crashed by 65.06% to $537511.9 in 2024, then surged by 94.81% to $1.0 million in 2025.
- According to Business Quant data, Finished Goods over the past three periods came in at $1.0 million, $537511.9, and $1.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.